News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Oct 31, 2006

  Insmed Inc. to Announce 2006 Third Quarter Financial Results
• Oct 31, 2006

  Jody LoMenzo Named Director, Investor Relations and Corporate Communications
• Oct 30, 2006

  Insmed to Present at Upcoming Conferences
• Oct 25, 2006

  Former Amgen Manufacturing Executive Joins Insmed
• Oct 24, 2006

  Insmed Announces Addition of Top 25 Patent Lawyer to Litigation Team
• Oct 17, 2006

  Insmed to Present at the BIO Investor Forum Meeting
• Oct 16, 2006

  Insmed Sues Tercica for False Advertising
• Oct 5, 2006

  Insmed Provides Update Concerning Virginia Unfair Competition Litigation
• Sep 6, 2006

  Insmed to Present at the BioCentury NewsMakers in the Biotech Industry Conference
• Aug 8, 2006

  Insmed Incorporated Reports Financial Results for the First Half and Second Quarter Ended June 30, 2006
• Aug 7, 2006

  Insmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET)
• Jul 31, 2006

  Phyton Biotech Signs Development Agreement With Insmed
• Jul 19, 2006

  Insmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET)
• Jul 11, 2006

  Insmed to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
• Jul 5, 2006

  European Medicines Agency Validates Insmed's Regulatory Application For Marketing IPLEX(TM) in Europe
• Jul 5, 2006

  Court Decision Means That Patent Dispute between Insmed and Tercica and Genentch Will Have to Be Resolved at Trial
• Jun 27, 2006

  Insmed Presents Positive IPLEX(TM) Data At ENDO 2006
• Jun 22, 2006

  Insmed Endocrine Society 2006 Update; Insmed Will Report Efficacy of IPLEX(TM) in Patients with Severe Insulin Resistance; Company Also to Present Data on the Unique Pharmacokinetics of IPLEX
• Jun 13, 2006

  Court Dismisses Baseless Unfair Business Practices Lawsuit That Was Brought Against Insmed
• Jun 9, 2006

  Insmed Provides Update on IPLEX(TM) Launch; Company Shares Details on Payer Usage Program and Pricing
• May 25, 2006

  INSMED Announces IPLEX(TM) Availability Nationwide for Children with Severe Short Stature; IPLEX Launch Marked By The First Product Shipments To Patients in States Across the Country
• May 12, 2006

  Insmed Incorporated to Present at the Rodman & Renshaw 3rd Annual Healthcare Conference
• May 8, 2006

  Insmed Incorporated Reports Financial Results for the First Quarter Ended March 31, 2006
• May 2, 2006

  Insmed Inc. to Webcast 2006 First Quarter Financial Results Conference Call, Monday May 8, 2006 at 4:30 p.m. (ET)
• May 1, 2006

  IPLEX(TM) Demonstrates Significant, Dose-Dependent Increases in Growth Rate

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download